First National Trust Co Holding in Amazon Com (AMZN) Cut by $339,800; Metropolitan Life Insurance Company Boosted Revance Therapeutics (RVNC) Position

September 14, 2018 - By Theresa McIntyre

Amazon.com, Inc. (NASDAQ:AMZN) Logo

Metropolitan Life Insurance Company increased its stake in Revance Therapeutics Inc (RVNC) by 25.82% based on its latest 2018Q2 regulatory filing with the SEC. Metropolitan Life Insurance Company bought 2,232 shares as the company’s stock declined 16.16% while stock markets rallied. The institutional investor held 10,875 shares of the health care company at the end of 2018Q2, valued at $298.52M, up from 8,643 at the end of the previous reported quarter. Metropolitan Life Insurance Company who had been investing in Revance Therapeutics Inc for a number of months, seems to be bullish on the $901.29M market cap company. The stock decreased 5.97% or $1.55 during the last trading session, reaching $24.4. About 341,707 shares traded or 30.33% up from the average. Revance Therapeutics, Inc. (NASDAQ:RVNC) has risen 7.74% since September 14, 2017 and is uptrending. It has underperformed by 7.88% the S&P500. Some Historical RVNC News: 24/05/2018 – REVANCE: RT002 GENERALLY SAFE-WELL-TOLERATED THROUGH WEEK 36; 29/05/2018 – Revance: Management, Existing Finance Team to Assume Duties on Interim Basis; 19/04/2018 – Revance Investor Day Highlights New Neuroscience lndications in Development; 23/04/2018 – DJ Revance Therapeutics Inc, Inst Holders, 1Q 2018 (RVNC); 08/05/2018 – REVANCE THERAPEUTICS INC QTRLY SHR LOSS $0.97; 08/05/2018 – Revance Releases First Quarter 2018 Results; 29/05/2018 – REVANCE THERAPEUTICS INC -LAUREN SILVERNAIL HAS RESIGNED AS REVANCE’S CHIEF FINANCIAL OFFICER AND CHIEF BUSINESS OFFICER, EFFECTIVE AS OF MAY 29, 2018; 20/04/2018 – Revance Therapeutics Closes Below 50-Day Moving Average; 02/04/2018 – Revance Therapeutics Expands Commercialization Team to Gear Up for Product Launch of RT002 Injectable; 19/04/2018 – Revance Investor Day Highlights New Neuroscience Indications in Development

First National Trust Co decreased its stake in Amazon Com Inc (AMZN) by 2.89% based on its latest 2018Q2 regulatory filing with the SEC. First National Trust Co sold 200 shares as the company’s stock rose 16.73% with the market. The institutional investor held 6,717 shares of the consumer services company at the end of 2018Q2, valued at $11.42 million, down from 6,917 at the end of the previous reported quarter. First National Trust Co who had been investing in Amazon Com Inc for a number of months, seems to be less bullish one the $964.74 billion market cap company. The stock decreased 0.60% or $11.9 during the last trading session, reaching $1977.97. About 1.01M shares traded. Amazon.com, Inc. (NASDAQ:AMZN) has risen 102.53% since September 14, 2017 and is uptrending. It has outperformed by 86.91% the S&P500. Some Historical AMZN News: 10/05/2018 – Amazon Is Said to Halt Google Shopping Ads as Rivalry Heats Up; 17/04/2018 – Beyond Spots & Dots Launches Programmatic Tactics for Small and Medium-Sized Businesses, Nonprofits, Government Entities and Educational Institutions; 27/04/2018 – AMAZON REPORTS AMENDED AND RESTATED CREDIT PACT; 30/05/2018 – AWS REPORTS GENERAL AVAILABILITY OF AMAZON NEPTUNE; 15/05/2018 – UPS, AMZN: $UPS To Bypass UPS, Amazon $AMZN Mimics Uber Tactics – TheInformation; 29/03/2018 – Whole Foods tests store signage to promote discounts for Amazon Prime members; 17/04/2018 – WhereverTV & APP Mastery Release Mobile Apps for Android, IOS and Amazon’s Fire TV Stick; 21/05/2018 – Tech or Retail? Ocado’s U.S. Deal Gives It Amazon-Like Valuation; 26/04/2018 – NFL, AMAZON RENEW STREAMING PACT FOR THURSDAY NIGHT FOOTBALL; 28/03/2018 – Amazon’s History Of Consumer Trust Will Help It Win Despite Obstacles, Says Analyst — MarketWatch

Metropolitan Life Insurance Company, which manages about $14.10B and $6171.51 billion US Long portfolio, decreased its stake in Ishares Msci Japan Etf by 426 shares to 14,047 shares, valued at $813.46 million in 2018Q2, according to the filing. It also reduced its holding in W. P. Carey Reit Inc (NYSE:WPC) by 201 shares in the quarter, leaving it with 8,603 shares, and cut its stake in Walt Disney (NYSE:DIS).

Investors sentiment decreased to 1.31 in Q2 2018. Its down 0.75, from 2.06 in 2018Q1. It fall, as 18 investors sold RVNC shares while 24 reduced holdings. 20 funds opened positions while 35 raised stakes. 32.89 million shares or 2.20% more from 32.18 million shares in 2018Q1 were reported. Swiss Commercial Bank holds 51,050 shares. State Street Corp stated it has 669,325 shares. Principal Grp Inc owns 0% invested in Revance Therapeutics, Inc. (NASDAQ:RVNC) for 125,908 shares. Credit Suisse Ag holds 0% or 24,809 shares in its portfolio. Renaissance stated it has 149,900 shares. Proshare Advsr Ltd Liability Corp holds 0% in Revance Therapeutics, Inc. (NASDAQ:RVNC) or 19,781 shares. Northern Tru reported 418,218 shares. Secor Cap Advsrs Ltd Partnership owns 0.04% invested in Revance Therapeutics, Inc. (NASDAQ:RVNC) for 18,823 shares. Fred Alger Management accumulated 30,000 shares or 0% of the stock. Los Angeles Capital Mngmt & Equity holds 0.01% of its portfolio in Revance Therapeutics, Inc. (NASDAQ:RVNC) for 42,900 shares. Bnp Paribas Arbitrage holds 1,035 shares. Rhumbline Advisers owns 31,453 shares. Royal Savings Bank Of Canada reported 25,629 shares. Nottingham Advsr Inc accumulated 11,312 shares. State Of New Jersey Common Pension Fund D holds 26,000 shares or 0% of its portfolio.

Among 13 analysts covering Revance Therapeutics (NASDAQ:RVNC), 11 have Buy rating, 0 Sell and 2 Hold. Therefore 85% are positive. Revance Therapeutics had 30 analyst reports since August 22, 2015 according to SRatingsIntel. SunTrust maintained the stock with “Buy” rating in Thursday, November 2 report. Cantor Fitzgerald maintained the stock with “Buy” rating in Thursday, April 12 report. The firm earned “Buy” rating on Tuesday, December 5 by Guggenheim. Aegis Capital initiated the stock with “Buy” rating in Tuesday, November 29 report. As per Saturday, August 22, the company rating was downgraded by Zacks. The stock of Revance Therapeutics, Inc. (NASDAQ:RVNC) earned “Hold” rating by Brean Capital on Tuesday, June 14. The stock of Revance Therapeutics, Inc. (NASDAQ:RVNC) has “Buy” rating given on Thursday, January 4 by Guggenheim. Aegis Capital maintained the stock with “Buy” rating in Thursday, June 8 report. On Thursday, March 1 the stock rating was maintained by Piper Jaffray with “Buy”. The stock has “Buy” rating by Cantor Fitzgerald on Thursday, November 2.

Another recent and important Revance Therapeutics, Inc. (NASDAQ:RVNC) news was published by Seekingalpha.com which published an article titled: “Revance slips 6% on Allergan takeout of Bonti” on September 14, 2018.

Since March 15, 2018, it had 0 insider purchases, and 3 insider sales for $203,905 activity. The insider GARDNER PHYLLIS sold $168,045. $98,393 worth of Revance Therapeutics, Inc. (NASDAQ:RVNC) shares were bought by Vickers Philip J.. Another trade for 6,452 shares valued at $204,148 was made by Browne L Daniel on Thursday, March 15. Allouche Cyril had sold 393 shares worth $11,142 on Friday, July 6.

Among 56 analysts covering Amazon.com (NASDAQ:AMZN), 53 have Buy rating, 0 Sell and 3 Hold. Therefore 95% are positive. Amazon.com had 323 analyst reports since July 21, 2015 according to SRatingsIntel. The stock has “Buy” rating by Robert W. Baird on Wednesday, June 21. The company was maintained on Friday, July 27 by JP Morgan. The firm earned “Outperform” rating on Friday, February 3 by RBC Capital Markets. The rating was maintained by JMP Securities on Friday, July 27 with “Market Outperform”. Canaccord Genuity maintained the shares of AMZN in report on Friday, July 29 with “Buy” rating. The stock of Amazon.com, Inc. (NASDAQ:AMZN) earned “Buy” rating by Guggenheim on Thursday, December 14. As per Tuesday, August 4, the company rating was maintained by Piper Jaffray. Wells Fargo maintained the stock with “Buy” rating in Friday, October 27 report. The firm has “Overweight” rating by Morgan Stanley given on Wednesday, August 29. The firm has “Buy” rating by Axiom Capital given on Monday, December 28.

Analysts await Amazon.com, Inc. (NASDAQ:AMZN) to report earnings on October, 25. They expect $3.21 earnings per share, up 517.31% or $2.69 from last year’s $0.52 per share. AMZN’s profit will be $1.57B for 154.05 P/E if the $3.21 EPS becomes a reality. After $5.07 actual earnings per share reported by Amazon.com, Inc. for the previous quarter, Wall Street now forecasts -36.69% negative EPS growth.

More notable recent Amazon.com, Inc. (NASDAQ:AMZN) news were published by: Bizjournals.com which released: “Even editors are taking this Amazon HQ2 thing personally” on September 13, 2018, also Seekingalpha.com with their article: “Amazon: 5 Reasons To Avoid This Stock” published on September 10, 2018, 247Wallst.com published: “Bezos Says Amazon Will Announce Second Headquarters by Year End” on September 14, 2018. More interesting news about Amazon.com, Inc. (NASDAQ:AMZN) were released by: Nasdaq.com and their article: “Could Amazon.com Be a Millionaire Maker Stock?” published on September 09, 2018 as well as Seekingalpha.com‘s news article titled: “Should You Be Buying Amazon?” with publication date: September 12, 2018.

First National Trust Co, which manages about $907.45 million US Long portfolio, upped its stake in Valero Energy Corp New (NYSE:VLO) by 6,342 shares to 85,937 shares, valued at $9.53 million in 2018Q2, according to the filing. It also increased its holding in Boeing Co (NYSE:BA) by 1,432 shares in the quarter, for a total of 26,840 shares, and has risen its stake in Thermo Fisher Scientific Inc (NYSE:TMO).

Investors sentiment increased to 1.34 in Q2 2018. Its up 0.26, from 1.08 in 2018Q1. It is positive, as 50 investors sold AMZN shares while 590 reduced holdings. 170 funds opened positions while 686 raised stakes. 268.42 million shares or 0.77% more from 266.38 million shares in 2018Q1 were reported. Invesco Limited invested 3.03% of its portfolio in Amazon.com, Inc. (NASDAQ:AMZN). Saturna Capital Corporation has 1,864 shares. Vigilant Capital Mgmt invested in 3.11% or 12,627 shares. Mitchell Sinkler Starr Pa holds 0.71% or 381 shares in its portfolio. Spinnaker Tru has invested 0.12% in Amazon.com, Inc. (NASDAQ:AMZN). Anderson Hoagland And holds 7.69% of its portfolio in Amazon.com, Inc. (NASDAQ:AMZN) for 8,110 shares. Scholtz & Com reported 5,527 shares stake. Regentatlantic Capital Ltd Liability Com owns 1,339 shares for 0.2% of their portfolio. Timessquare Capital Management Ltd Liability Co invested in 7,563 shares. Lombard Odier Asset Management (Usa) Corp has invested 0.84% of its portfolio in Amazon.com, Inc. (NASDAQ:AMZN). Picton Mahoney Asset Mngmt invested in 27,230 shares. Middleton And Ma invested in 18,566 shares. Ajo LP stated it has 22,338 shares. Prio Wealth Partnership invested 2.12% in Amazon.com, Inc. (NASDAQ:AMZN). Dakota Wealth Mngmt invested in 3,411 shares.

Since March 20, 2018, it had 0 buys, and 21 sales for $59.19 million activity. STONESIFER PATRICIA Q sold $2.17M worth of stock. On Tuesday, May 15 the insider Jassy Andrew R sold $2.72M. Zapolsky David sold $3.66 million worth of stock or 1,927 shares. On Wednesday, August 29 the insider Blackburn Jeffrey M sold $8.02M. McGrath Judith A sold $952,500 worth of stock or 500 shares. Reynolds Shelley had sold 435 shares worth $824,513 on Wednesday, August 15.

Amazon.com, Inc. (NASDAQ:AMZN) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts